Drug:
SV-BR-1-GM (Bria-IMT) in combination with Retifanlimab
Indication:
Breast Cancer, Breast Cancer Metastatic, Breast Neoplasm, End Stage Cancer, Metastatic Breast Cancer, Other advanced solid tumors
Region:
US
Study of the Bria-IMT Regimen and CPI vs Physicians’ Choice in Advanced Metastatic Breast Cancer. (BRIA-ABC )
A Randomized, Open-label Study Comparing the Bria-IMT regimen in combination with Check Point Inhibitor vs Physician’s Choice in Metastatic Breast Cancer
This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor [Retifanlimab], versus Treatment of Patients’/Physicians’ Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies available.
Experimental:
- Bria-IMT Regimen + CPI
- Bria-IMT Regimen Alone
Active Comparator:
- Treatment of Physician’s Choice
Inclusion Criteria
- Be ≥ 18 years of age
- You are being asked to take part in this study because you have recurrent breast cancer that has not responded to traditional treatments
- Able to travel to one of our clinical sites listed below
- You will not receive any compensation (payment) for participating in this study. Travel, lodging, and other reasonable expenses may be reimbursed by the sponsor when requested by the study doctor but must be pre-approved by the sponsor
Locations
California Locations
Bakersfield, California, United States, 93309
Comprehensive Blood and Cancer Center
Contact: Nicole Ward
661-862-8548 [email protected]
Principal Investigator: Ravi Patel, MD
Irvine, California, United States, 92618
Hoag Hospital Center
Contact: Keeva Bromley
[email protected]
Principal Investigator: Chaitali Nangia, MD
Irvine, California, United States, 92618
Hoag Hospital Irvine
Contact:Kevva Bromey
[email protected]
Principal Investigator: Chaitali Nangia, MD
San Diego, California, United States, 92037
UC San Diego
Contact: Odelia Ha
858-534-8248 [email protected]
Principal Investigator: Rebecca A. Shatsky, MD
Santa Monica, California, United States, 90404
St. John’s Cancer Center
Contact: Pamela Torres, CCRC
[email protected]
Principal Investigator: Parvin Peddi, MD
Torrance, California, United States, 90505
Torrance Memorial Cancer Center
Contact: Jessica Yoshinaga
310-750-3378 [email protected]
Contact: Crystal Taylor
[email protected]
Principal Investigator: David Chan, MD
Connecticut Locations
New Haven, Connecticut, United States, 06511
Smilow Cancer Hospital at Yale New Haven
Contact: Carl Brown
475-241-1065 [email protected]
Principal Investigator: Adriana Kahn, MD
Florida Locations
Coral Gables, Florida, United States, 33146
University of Miami-SCCC-Lennar
Contact: Yisell Gongora
305-270-3467 [email protected]
Contact: Irene Marino
3052439221 [email protected]
Principal Investigator: Lawrence Negret, MD
Sub-Investigator: Carmen Calfa, MD
Miami, Florida, United States, 33136
University Of Miami-SCCC-Miami
Contact: Maynela Quinones
305-243-2457 [email protected]
Contact: Irene Marino
305-243-9221 [email protected]
Principal Investigator: Lawrence Negret, MD
Sub-Investigator: Carmen Calfa, MD
Orlando, Florida, United States, 32804
Advent Health – Orlando
Contact: Ashley Young, CCRC
407-303-2284 [email protected]
Contact: Valeria BURKOVSKAYA, CCRC
407-303-2283 [email protected]
Principal Investigator: Carlos Alemany, MD
Plantation, Florida, United States, 33324
University of Miami-SCCC-Plantation
Contact: Deborah Conte, CCRC
954-210-1171 [email protected]
Contact: Irene Marino
3052439221 [email protected]
Principal Investigator: Lawrence Negret, MD
Sub-Investigator: Carmen Calfa, MD
Illinois Locations
Chicago, Illinois, United States, 60611
Northwestern University
Contact: Nina Garcia
312-695-1352 [email protected]
Principal Investigator: Regina Stein, MD
Springfield, Illinois, United States, 62702
Southern Illinois University-Simmons
Contact: Kathy Robinson
217-545-1946 [email protected]
Principal Investigator: Krishna Rao, MD
Urbana, Illinois, United States, 61801
Carle Foundation Cancer Institute-Urbana
Contact: Christine Rogers
217-383-3394 [email protected]
Principal Investigator: Kendrith Rowland, MD
Indiana Locations
Dyer, Indiana, United States, 46311
Northwest Cancer Center
Contact: Mariela Abad
219-924-8178 ext 279 [email protected]
Principal Investigator: Shruti Singh, MD
Kansas Locations
Kansas City, Kansas, United States, 66204
AMR Kansas City Oncology
Contact: Jennifer Ross, CCRC
913-386-7556 [email protected]
Contact: Jason Huntington, Site Manager (913) 386-7556
Principal Investigator: Jaswinder Singh, MD
Louisiana Locations
Marrero, Louisiana, United States, 70072
Care Access-Marrero
Contact: William Robinson, RN
351-227-7173 [email protected]
Principal Investigator: Shibu Varughese, MD
Maryland Locations
Bethesda, Maryland, United States, 20817
The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A.
Contact: Jenelle Larkin, CCRC
301-571-0019 ext 69355 [email protected]
Contact: Natalie Bongiorno, RN, MSHS
301-571-2016 [email protected]
Principal Investigator: Ralph Boccia, MD
Nebraska Locations
Omaha, Nebraska, United States, 68130
Nebraska Cancer Specialists
Contact: Heather Cordes, CCRC
402-691-6970 [email protected]
Contact: Scott Degenhardt
402-691-5257 [email protected]
Principal Investigator: Geetha Palaniappan, MD
New York Locations
Babylon, New York, United States, 11702
New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Babylon)
Contact: Lauren Gianelli
855-528-7322 [email protected]
Principal Investigator: Richard Zuniga, MD
Bronx, New York, United States, 10469
New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C (Bronx)
Contact: Lauren Gianelli
855-528-7322 [email protected]
Principal Investigator: Richard Zuniga, MD
New Hyde Park, New York, United States, 11042
New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(New Hyde Park)
Contact: Lauren Gianelli
[email protected]
Principal Investigator: Richard Zuniga, MD
New York, New York, United States, 10016
Manhattan Hematology /Oncology Associates
Contact: Patricia Mccullough, RN
212-689-6791 [email protected]
Principal Investigator: Alec Goldenberg, MD
New York, New York, United States, 10028
New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C (NY)
Contact: Lauren Gianelli
[email protected]
Principal Investigator: Richard Zuniga, MD
Patchogue, New York, United States, 11772
New York Cancers & Blood Specialists_North Shore Hematology Oncology Assocaites P.C (Patchogue)
Contact: Lauren Bilka, LPN
631-675-5075 [email protected]
Principal Investigator: Richard Zuniga, MD
Sub-Investigator: Gurmohan Syali, MD
Port Jefferson Station, New York, United States, 11776
New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Port Jefferson Station2)
Contact: Lauren Gianelli
855-528-7322 [email protected]
Principal Investigator: Richard Zuniga, MD
Port Jefferson Station, New York, United States, 11776
New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1)
Contact: Lauren Gianelli
855-528-7322 [email protected]
Principal Investigator: Richard Zuniga, MD
Port Jefferson Station, New York, United States, 11776
New York Cancers & Blood Specialists
Contact: Lauren Gianelli
855-528-7322 [email protected]
Contact: Laura Brady-Parisi, LPN, LPN
631-675-5075 [email protected]
Principal Investigator: Richard Zuniga, MD
Riverhead, New York, United States, 11901
New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Riverhead)
Contact: Lauren Gianelli
[email protected]
Principal Investigator:
Richard Zuniga, MD
Ohio Locations
Canton, Ohio, United States, 44718
Gabrail Cancer & Research Center
Contact: Carrie Smith, RN
330-492-3345 [email protected]
Principal Investigator: Nashat Gabrail, MD
Cleveland, Ohio, United States, 44195
Cleveland Clinic
Contact: Mariah Branem, CCRC
866-320-4573 [email protected]
Principal Investigator: Azka Ali, MD
Texas Locations
Dallas, Texas, United States, 75246
Texas Oncology-Baylor Charles A. Sammons Cancer Center
Contact: Melissa Melendez-Salazar, RN
214-370-1038 [email protected]
Contact: Jessica Medina, CCRC
214-370-1989 [email protected]
Principal Investigator: Joyce O’Shaughnessy, MD
Dallas, Texas, United States, 75251
Mary Crowley Cancer Research
Contact: Akhil Valiyil, CCRC
972-566-3061 [email protected]
Contact: Angela Hotchkiss
214-658-1958 [email protected]
Principal Investigator: Minal Barve, MD
Edinburg, Texas, United States, 78539
DHR Health Oncology Institute
Contact: Edgar Lopez
956-362-2394 [email protected]
Contact: Vaney Capetillo
[email protected]
Principal Investigator: Jose Cruz, MD
Fredericksburg, Texas, United States, 78624
Texas Oncology – Fredericksburg
Contact: Brenda Travieso
[email protected]
Principal Investigator: Emmalind Aponte, MD
Harlingen, Texas, United States, 78550
Texas Oncology – Harlingen
Contact: Nereida Salinas
[email protected]
Principal Investigator: Alvaro Restrepo, MD
McAllen, Texas, United States, 78503
Texas Oncology McAllen
Contact: Nereida Salinas, RN
956-687-5150 [email protected]
Principal Investigator: Alvaro Restrepo, MD
New Braunfels, Texas, United States, 78130
Texas Oncology, New Braunfels
Contact: Brenda Travieso
[email protected]
Principal Investigator: Emmalind Aponte, MD
San Antonio, Texas, United States, 78216
Texas Oncology-San Antonio Cancer Care
Contact: Shannon Syring, RN
210-419-2608 [email protected]
Contact: Norma Norris, RN
210-595-5613 [email protected]
Principal Investigator: Emmalind Aponte, MD
San Antonio, Texas, United States, 78217
Texas Oncology – San Antonio Northeast
Contact: Brenda Travieso
[email protected]
Principal Investigator: Emmalind Aponte, MD
San Antonio, Texas, United States, 78258
Texas Oncology – San Antonio Stone Oak
Contact: Brenda Travieso
[email protected]
Principal Investigator: Emmalind Aponte, MD
Webster, Texas, United States, 77598
Tranquil Clinical Research
Contact: Veronica D. Mohammed, RN
713-907-6054 [email protected]
Contact: Patricia Roark, RN
346-435-9438 [email protected]
Principal Investigator: John Knecht, MD
Weslaco, Texas, United States, 78596
Texas Oncology – Weslaco
Contact: Nereida Salinas, RN
[email protected]
Principal Investigator: Alvaro Restrepo, MD
Virginia Locations
Fredericksburg, Virginia, United States, 22408
Hematology-Oncology Associates of Fredericksburg, Inc
Contact: Ashley Lawrence, RN, OCN
540-371-0079 ext 149 [email protected]
Contact: Amber Spurley, RN
540-371-0079 [email protected]
Principal Investigator: Christopher N. Vaughn, MD
Washington Locations
Spokane Valley, Washington, United States, 99218
Cancer Care Northwest
Contact: Ronaye Wagner, RN, MSN
509-228-1680 [email protected]
Contact: Bethany Giachetti, BS, CCRC
509-228-1684 [email protected]
Principal Investigator: Kristine Rinn, MD
Spokane, Washington, United States, 99202
Cancer Care Northwest-1 (601 S. Sherman)
Contact: Ronaye Wagner
[email protected]
Principal Investigator: Kristine Rinn, MD
Spokane, Washington, United States, 99218
Cancer Care Northwest_2 (605 E. Holland)
Contact: Ronaye Wagner
[email protected]
Principal Investigator: Kristine Rinn, MD
Wisconsin Location
Sheboygan, Wisconsin, United States, 53081
Sheboygan Cancer & Blood Specialists
Contact: Maria Splittgerber
920-452-1650 ext 318 [email protected]
Principal Investigator: S. Mark Bettag, MD
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06072612
Study Sponsor: BriaCell Therapeutics Corp.
Sponsor Protocol Number: BC-IMT-04